Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

The regional Stoxx 600 index is down 0.18%, with France's CAC 40 and Germany's DAX lower by 0.43% and 0.22%, respectively.

From Novo Nordisk to UnitedHealth, onetime chief executives are returning to guide their former organizations in times of ...

MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

How Ozempic’s Maker Lost Its Grip on the Obesity Market It Created ...

Ozempic helped Novo Nordisk gain an early lead in the weight loss industry, but competition is nipping at the company's heels ...

If this trajectory continues, doctors say millions more people would benefit from them—maybe even one-third to a majority of adults.

If you are looking to get a weight loss drug but lack insurance coverage, telehealth websites such as Ro, Hers and Mochi ...

Facing steep competition, Novo Nordisk has slashed the price for its weight loss drug Wegovy — temporarily, at least.

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss ...